CVS HEALTH CORPORATION earnings per share and revenue
On Oct 29, 2025, CVS reported earnings of 1.60 USD per share (EPS) for Q3 25, beating the estimate of 1.38 USD, resulting in a 15.69% surprise. Revenue reached 102.87 billion, compared to an expected 99.84 billion, with a 3.04% difference. The market reacted with a -1.95% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 26 analysts forecast an EPS of 1.00 USD, with revenue projected to reach 104.63 billion USD, implying an decrease of -37.50% EPS, and increase of 1.71% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Danaher Corporation
Report Date
Jan 28, 2026 For Q4 25
Estimate
$2.17
Actual
$2.23
Surprise
+2.56%
HCA Healthcare, Inc.
Report Date
Jan 27, 2026 For Q4 25
Estimate
$7.53
Actual
$8.14
Surprise
+8.05%
Elevance Health, Inc.
Report Date
Jan 28, 2026 For Q4 25
Estimate
$3.12
Actual
$3.33
Surprise
+6.46%
Cencora, Inc.
Report Date
Feb 04, 2026 For Q1 26
Estimate
$4.07
Actual
$4.08
Surprise
+0.16%
Revvity, Inc.
Report Date
Feb 02, 2026 For Q4 25
Estimate
$1.58
Actual
$1.70
Surprise
+7.45%
InnovAge Holding Corp. Common Stock
Report Date
Feb 03, 2026 For Q2 26
Estimate
$0.04
Actual
$0.08
Surprise
+96.08%
Embecta Corp. Common Stock
Report Date
Feb 05, 2026 For Q1 26
Estimate
$0.68
Actual
$0.71
Surprise
+3.89%
FAQ
What were CVS HEALTH CORPORATION's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, CVS HEALTH CORPORATION reported EPS of $1.60, beating estimates by 15.69%, and revenue of $102.87B, 3.04% above expectations.
How did the market react to CVS HEALTH CORPORATION's Q3 2025 earnings?
The stock price moved down -1.95%, changed from $82.20 before the earnings release to $80.60 the day after.
When is CVS HEALTH CORPORATION expected to report next?
The next earning report is scheduled for Feb 11, 2026.
What are the forecasts for CVS HEALTH CORPORATION's next earnings report?
Based on 26
analysts, CVS HEALTH CORPORATION is expected to report EPS of $1.00 and revenue of $104.63B for Q4 2025.